<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00706394</url>
  </required_header>
  <id_info>
    <org_study_id>CP03-023</org_study_id>
    <nct_id>NCT00706394</nct_id>
  </id_info>
  <brief_title>34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms</brief_title>
  <official_title>Prospective, Multicenter, Single Arm Phase II Study of the Powerlink 34mm Cuff for the Endovascular Repair of Abdominal Aortic Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Endologix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endologix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of anatomical fixation with a 34mm proximal extension
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 34mm proximal extension stent graft is intended to augment the primary 28mm infrarenal
      bifurcated stent graft to accommodate patient anatomy (neck diameters up to 32mm) and provide
      an effective seal to prevent/repair proximal Type I endoleaks.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2005</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">September 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>Yes</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proximal Type I endoleak</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delivery success, deployment success, stent graft apposition to the vessel wall, device integrity, patency, occlusion, migration and Type III endoleak.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Powerlink 34mm cuff stent graft</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endologix Powerlink 34 mm stent graft cuff</intervention_name>
    <description>Endovascular abdominal aortic aneurysm repair</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Endologix Powerlink 34mm cuff [model 34-34-80L]</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old or older

          -  Informed consent understood and signed

          -  Will comply with protocol follow-up requirements

          -  Candidate for conventional open surgical repair

          -  Aneurysm outer diameter is one or more of the following:

               -  greater than or equal to 4.0cm

               -  greater than or equal to 3.0cm (saccular aneurysm)

               -  greater than or equal to twice the normal aortic outer diameter

               -  rapidly growing (greater than or equal to 5mm over 6 months)

          -  Proximal non-aneurysmal aortic neck fixation length greater than or equal to 1.5cm
             between the renal arteries and the aneurysm

          -  Non-aneurysmal proximal aortic neck inner diameter between 23 and 32mm

          -  Iliac artery internal diameter greater than or equal to 8 mm

        Exclusion Criteria:

          -  Life expectancy &lt;2 years

          -  Participating in another clinical study

          -  Pregnant or lactating women

          -  Acutely ruptured/leaking aneurysm

          -  Traumatic vascular injury

          -  Other medical or psychiatric problems

          -  Contraindication to non-ionic contrast media or anticoagulants

          -  Coagulopathy or bleeding disorder

          -  Active systemic or localized groin infection

          -  Indispensable inferior mesenteric artery

          -  Connective tissue disease (e.g., Marfan's Syndrome)

          -  Creatinine level &gt;1.7 mg/dl

          -  Renal transplant patient

          -  Proximal attachment site &gt;60ยบ angle to the aneurysm body

          -  Iliac arteries &gt;90ยบ angle

          -  &lt;1.5 cm of non-aneurysmal common iliac artery above the iliac bifurcation on both
             sides [One internal iliac artery is required to remain patent]

          -  Thrombus &gt;30% at implantation site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward Y Woo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital at the University of Pennsylvania, Philadelphia, PA 19104, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>O. W. Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>William Beaumont Hospital, Royal Oak, MI 48073, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James G. Melton, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma Cardiovascular Research Group, Oklahoma City, OK 73120, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven H. Tyndall, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nebraska Heart Hospital, Lincoln, NE 68526, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William M. Moore, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lexington Medical Center, West Columbia, SC 29169, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salem George, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baptist Hospital East, Louisville, KY 40207, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kerry C. Prewitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Joseph Medical Center, Towson, MD 21204, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Anain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sisters of Charity Hospital, Buffalo, NY 14214, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Beasley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Medical Center, Miami Beach, FL 33140, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barry T. Katzen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baptist Cardiac and Vascular Institute, Miami, FL 33176, United States</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Cardiac and Vascular Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Hospital East</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Medical Center</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nebraska Heart Institute</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sisters of Charity Hospital</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Cardiovascular Associates</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital at the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lexington Medical Center</name>
      <address>
        <city>West Columbia</city>
        <state>South Carolina</state>
        <zip>29169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Jordan WD Jr, Moore WM Jr, Melton JG, Brown OW, Carpenter JP; Endologix Investigators. Secure fixation following EVAR with the Powerlink XL System in wide aortic necks: results of a prospective, multicenter trial. J Vasc Surg. 2009 Nov;50(5):979-86. doi: 10.1016/j.jvs.2009.05.057. Epub 2009 Aug 12.</citation>
    <PMID>19679425</PMID>
  </results_reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2008</study_first_submitted>
  <study_first_submitted_qc>June 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2008</study_first_posted>
  <last_update_submitted>September 12, 2011</last_update_submitted>
  <last_update_submitted_qc>September 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Powerlink</keyword>
  <keyword>34mm</keyword>
  <keyword>Abdominal Aortic Aneurysm</keyword>
  <keyword>EVAR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

